Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)–Coalition IV trial

Renato D. Lópes, Pedro Gabriel Melo de Barros e Silva, Remo H.M. Furtado, Ariane Vieira Scarlatelli Macedo, Eduardo Ramacciotti, Lucas Petri Damini, Bruna Bronhara, Alexandre Biasi Cavalcanti, Régis Goulart Rosa, Luciano César Pontes Azevedo, Viviane Cordeiro Veiga, Flávia Ribeiro Machado, Luiz Eduardo Fonteles Ritt, Priscilla de Aquino Martins, John H. Alexander, Álvaro Avezum, Otávio Berwanger